212 related articles for article (PubMed ID: 32323916)
41. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
42. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
[TBL] [Abstract][Full Text] [Related]
44. [Transcription factor RUNX1].
Markova EN; Petrova NV; Razin SV; Kantidze OL
Mol Biol (Mosk); 2012; 46(6):846-59. PubMed ID: 23350231
[TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
Harada Y; Harada H
J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
[TBL] [Abstract][Full Text] [Related]
46. Genetic alterations of the cohesin complex genes in myeloid malignancies.
Thota S; Viny AD; Makishima H; Spitzer B; Radivoyevitch T; Przychodzen B; Sekeres MA; Levine RL; Maciejewski JP
Blood; 2014 Sep; 124(11):1790-8. PubMed ID: 25006131
[TBL] [Abstract][Full Text] [Related]
47. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
48. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
49. RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis.
Lichtinger M; Ingram R; Hannah R; Müller D; Clarke D; Assi SA; Lie-A-Ling M; Noailles L; Vijayabaskar MS; Wu M; Tenen DG; Westhead DR; Kouskoff V; Lacaud G; Göttgens B; Bonifer C
EMBO J; 2012 Nov; 31(22):4318-33. PubMed ID: 23064151
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
51. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
[TBL] [Abstract][Full Text] [Related]
52. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of CCAAT/Enhancer Binding Protein (C/EBP) Alpha (CEBPA) and Runt-Related Transcription Factor 1 (RUNX1) Expression in Patients with De Novo Acute Myeloid Leukemia.
Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Farsani MA
Ann Hum Genet; 2017 Nov; 81(6):276-283. PubMed ID: 28895127
[TBL] [Abstract][Full Text] [Related]
54. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
55. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
56. Chemogenomic Landscape of
Simon L; Lavallée VP; Bordeleau ME; Krosl J; Baccelli I; Boucher G; Lehnertz B; Chagraoui J; MacRae T; Ruel R; Chantigny Y; Lemieux S; Marinier A; Hébert J; Sauvageau G
Clin Cancer Res; 2017 Nov; 23(22):6969-6981. PubMed ID: 28855357
[No Abstract] [Full Text] [Related]
57. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
58. Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective.
Hayashi Y; Harada Y; Harada H
Leukemia; 2022 May; 36(5):1203-1214. PubMed ID: 35354921
[TBL] [Abstract][Full Text] [Related]
59. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
